Terry Smith - Fundsmith
Holding/activity history for Catalyst Pharmaceuticals, Inc. (CPRX)
← All CPRX superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 844,887 | 0.16 | Reduce 74.88% | 0.34 | $22.13–25.53 · VW $23.91i | $20,919,402 | SEC |
| 2025 Q4 | 3,363,807 | 0.46 | $23.34 | $78,511,255 | SEC | ||
| 2025 Q3 | 3,363,807 | 0.33 | Add 24.17% | 0.06 | $19.05–22.53 · VW $20.63i | $66,266,998 | SEC |
| 2025 Q2 | 2,709,086 | 0.26 | Add 25.93% | 0.05 | $20.40–26.58 · VW $23.32i | $58,787,166 | SEC |
| 2025 Q1 | 2,151,274 | 0.24 | Buy | 0.24 | $19.15–26.16 · VW $22.73i | $52,168,395 | SEC |
Price snapshot:
Current price$31.48
Avg. buy price$22.94
+/- since buy37.22%
52-week low$19.05
52-week high$32.56